Godi A - Search Results

1

Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection.

Kamuyu G, Coelho da Silva F, Tenet V, Schussler J, Godi A, Herrero R, Porras C, Mirabello L, Schiller JT, Sierra MS, Kreimer AR, Clifford GM, Beddows S. Kamuyu G, et al. Among authors: godi a. Nat Commun. 2024 Feb 21;15(1):1608. doi: 10.1038/s41467-024-45807-w. Nat Commun. 2024. PMID: 38383518 Free PMC article.

2

The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.

Bissett SL, Godi A, Beddows S. Bissett SL, et al. Among authors: godi a. Sci Rep. 2016 Dec 22;6:39730. doi: 10.1038/srep39730. Sci Rep. 2016. PMID: 28004837 Free PMC article. Clinical Trial.

3

Impact of naturally occurring variation in the human papillomavirus (HPV) 33 capsid proteins on recognition by vaccine-induced cross-neutralizing antibodies.

Godi A, Bissett SL, Miller E, Beddows S. Godi A, et al. J Gen Virol. 2017 Jul;98(7):1755-1761. doi: 10.1099/jgv.0.000829. Epub 2017 Jul 8. J Gen Virol. 2017. PMID: 28691664

4

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies.

Godi A, Kemp TJ, Pinto LA, Beddows S. Godi A, et al. J Infect Dis. 2019 Nov 6;220(12):1940-1945. doi: 10.1093/infdis/jiz401. J Infect Dis. 2019. PMID: 31412122 Free PMC article.

5

Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies.

Godi A, Vaghadia S, Cocuzza C, Miller E, Beddows S. Godi A, et al. Microbiol Spectr. 2022 Jun 29;10(3):e0077922. doi: 10.1128/spectrum.00779-22. Epub 2022 Apr 27. Microbiol Spectr. 2022. PMID: 35475682 Free PMC article.

6

Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities.

Bissett SL, Draper E, Myers RE, Godi A, Beddows S. Bissett SL, et al. Among authors: godi a. Vaccine. 2014 Feb 26;32(10):1139-46. doi: 10.1016/j.vaccine.2014.01.008. Epub 2014 Jan 15. Vaccine. 2014. PMID: 24440205 Free PMC article.

7

Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage.

Marongiu L, Godi A, Parry JV, Beddows S. Marongiu L, et al. Among authors: godi a. Infect Genet Evol. 2014 Aug;26(100):8-13. doi: 10.1016/j.meegid.2014.05.009. Epub 2014 May 10. Infect Genet Evol. 2014. PMID: 24823962 Free PMC article.

8

Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage.

Marongiu L, Godi A, Parry JV, Beddows S. Marongiu L, et al. Among authors: godi a. BMC Cancer. 2014 May 30;14:384. doi: 10.1186/1471-2407-14-384. BMC Cancer. 2014. PMID: 24885011 Free PMC article.

9

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins.

Bissett SL, Mattiuzzo G, Draper E, Godi A, Wilkinson DE, Minor P, Page M, Beddows S. Bissett SL, et al. Among authors: godi a. Vaccine. 2014 Nov 12;32(48):6548-55. doi: 10.1016/j.vaccine.2014.07.116. Epub 2014 Sep 6. Vaccine. 2014. PMID: 25203446 Free PMC article.

10

Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.

Bissett SL, Godi A, Fleury MJ, Touze A, Cocuzza C, Beddows S. Bissett SL, et al. Among authors: godi a. J Virol. 2015 Aug;89(15):7748-57. doi: 10.1128/JVI.00842-15. Epub 2015 May 20. J Virol. 2015. PMID: 25995264 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters